179 related articles for article (PubMed ID: 34127738)
1. Y disruption, autosomal hypomethylation and poor male lung cancer survival.
Willis-Owen SAG; Domingo-Sabugo C; Starren E; Liang L; Freidin MB; Arseneault M; Zhang Y; Lu SK; Popat S; Lim E; Nicholson AG; Riazalhosseini Y; Lathrop M; Cookson WOC; Moffatt MF
Sci Rep; 2021 Jun; 11(1):12453. PubMed ID: 34127738
[TBL] [Abstract][Full Text] [Related]
2. ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D.
Komura K; Yoshikawa Y; Shimamura T; Chakraborty G; Gerke TA; Hinohara K; Chadalavada K; Jeong SH; Armenia J; Du SY; Mazzu YZ; Taniguchi K; Ibuki N; Meyer CA; Nanjangud GJ; Inamoto T; Lee GM; Mucci LA; Azuma H; Sweeney CJ; Kantoff PW
J Clin Invest; 2018 Jul; 128(7):2979-2995. PubMed ID: 29863497
[TBL] [Abstract][Full Text] [Related]
3. Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma.
Arseneault M; Monlong J; Vasudev NS; Laskar RS; Safisamghabadi M; Harnden P; Egevad L; Nourbehesht N; Panichnantakul P; Holcatova I; Brisuda A; Janout V; Kollarova H; Foretova L; Navratilova M; Mates D; Jinga V; Zaridze D; Mukeria A; Jandaghi P; Brennan P; Brazma A; Tost J; Scelo G; Banks RE; Lathrop M; Bourque G; Riazalhosseini Y
Sci Rep; 2017 Mar; 7():44876. PubMed ID: 28332632
[TBL] [Abstract][Full Text] [Related]
4. Differential
Lin S; Tian C; Li J; Liu B; Ma T; Chen K; Gong W; Wang JM; Huang J
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786615
[TBL] [Abstract][Full Text] [Related]
5. Histone demethylase KDM5D upregulation drives sex differences in colon cancer.
Li J; Lan Z; Liao W; Horner JW; Xu X; Liu J; Yoshihama Y; Jiang S; Shim HS; Slotnik M; LaBella KA; Wu CJ; Dunner K; Hsu WH; Lee R; Khanduri I; Terranova C; Akdemir K; Chakravarti D; Shang X; Spring DJ; Wang YA; DePinho RA
Nature; 2023 Jul; 619(7970):632-639. PubMed ID: 37344599
[TBL] [Abstract][Full Text] [Related]
6. Increased Mars2 expression upon microRNA-4661-5p-mediated KDM5D downregulation is correlated with malignant degree of gastric cancer cells.
Gu J; Chu K
Cell Biol Int; 2021 Oct; 45(10):2118-2128. PubMed ID: 34273914
[TBL] [Abstract][Full Text] [Related]
7. LINE-1 hypomethylation is associated to specific clinico-pathological features in Stage I non-small cell lung cancer.
Imperatori A; Sahnane N; Rotolo N; Franzi F; Nardecchia E; Libera L; Romualdi C; Cattoni M; Sessa F; Dominioni L; Furlan D
Lung Cancer; 2017 Jun; 108():83-89. PubMed ID: 28625654
[TBL] [Abstract][Full Text] [Related]
8. A gene expression-based single sample predictor of lung adenocarcinoma molecular subtype and prognosis.
Liljedahl H; Karlsson A; Oskarsdottir GN; Salomonsson A; Brunnström H; Erlingsdottir G; Jönsson M; Isaksson S; Arbajian E; Ortiz-Villalón C; Hussein A; Bergman B; Vikström A; Monsef N; Branden E; Koyi H; de Petris L; Patthey A; Behndig AF; Johansson M; Planck M; Staaf J
Int J Cancer; 2021 Jan; 148(1):238-251. PubMed ID: 32745259
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modifications in
Wei Y; Liang J; Zhang R; Guo Y; Shen S; Su L; Lin X; Moran S; Helland Å; Bjaanæs MM; Karlsson A; Planck M; Esteller M; Fleischer T; Staaf J; Zhao Y; Chen F; Christiani DC
Clin Epigenetics; 2018; 10():41. PubMed ID: 29619118
[TBL] [Abstract][Full Text] [Related]
10. Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer.
Gentles AJ; Bratman SV; Lee LJ; Harris JP; Feng W; Nair RV; Shultz DB; Nair VS; Hoang CD; West RB; Plevritis SK; Alizadeh AA; Diehn M
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26286589
[TBL] [Abstract][Full Text] [Related]
11. Molecular Markers for Long-term Survival in Stage IIIA (N2) NSCLC Patients.
Nastase A; Dima SO; Lupo A; Laszlo V; Tagett R; Draghici S; Georgescu ME; Nechifor A; Berbece S; Popescu I; Alifano M; Klepetko W; Grigoroiu M
Cancer Genomics Proteomics; 2022; 19(1):94-104. PubMed ID: 34949662
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
[No Abstract] [Full Text] [Related]
13. The Histone Demethylase KDM5D Drives Sex Differences in Colorectal Cancer.
Cancer Discov; 2023 Aug; 13(8):1761. PubMed ID: 37387591
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic investigation of BIRC6 and SIRT1 protein expression level as potential prognostic biomarkers in patients with non-small cell lung cancer.
Gharabaghi MA
Clin Respir J; 2018 Feb; 12(2):633-638. PubMed ID: 27768839
[TBL] [Abstract][Full Text] [Related]
15. A ten-gene signature-based risk assessment model predicts the prognosis of lung adenocarcinoma.
Jiang H; Xu S; Chen C
BMC Cancer; 2020 Aug; 20(1):782. PubMed ID: 32819300
[TBL] [Abstract][Full Text] [Related]
16. Increased Expression of Y-Encoded Demethylases During Differentiation of Human Male Neural Stem Cells.
Pottmeier P; Doszyn O; Peuckert C; Jazin E
Stem Cells Dev; 2020 Dec; 29(23):1497-1509. PubMed ID: 33040644
[TBL] [Abstract][Full Text] [Related]
17. Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression.
Komura K; Jeong SH; Hinohara K; Qu F; Wang X; Hiraki M; Azuma H; Lee GS; Kantoff PW; Sweeney CJ
Proc Natl Acad Sci U S A; 2016 May; 113(22):6259-64. PubMed ID: 27185910
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis.
Duruisseaux M; Martínez-Cardús A; Calleja-Cervantes ME; Moran S; Castro de Moura M; Davalos V; Piñeyro D; Sanchez-Cespedes M; Girard N; Brevet M; Giroux-Leprieur E; Dumenil C; Pradotto M; Bironzo P; Capelletto E; Novello S; Cortot A; Copin MC; Karachaliou N; Gonzalez-Cao M; Peralta S; Montuenga LM; Gil-Bazo I; Baraibar I; Lozano MD; Varela M; Ruffinelli JC; Palmero R; Nadal E; Moran T; Perez L; Ramos I; Xiao Q; Fernandez AF; Fraga MF; Gut M; Gut I; Teixidó C; Vilariño N; Prat A; Reguart N; Benito A; Garrido P; Barragan I; Emile JF; Rosell R; Brambilla E; Esteller M
Lancet Respir Med; 2018 Oct; 6(10):771-781. PubMed ID: 30100403
[TBL] [Abstract][Full Text] [Related]
19. KDM5D inhibits the transcriptional activation of FKBP4 by suppressing the expression of E2F1 in colorectal cancer in males.
Liu M; Gao N
Biochem Pharmacol; 2021 Dec; 194():114814. PubMed ID: 34688635
[TBL] [Abstract][Full Text] [Related]
20. The Divergence of Neandertal and Modern Human Y Chromosomes.
Mendez FL; Poznik GD; Castellano S; Bustamante CD
Am J Hum Genet; 2016 Apr; 98(4):728-34. PubMed ID: 27058445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
